/ TerminatedNot ApplicableIIT NanoSpectrometer Biomarker Discovery and Confirmation Study
This study will evaluate exhaled volatile organic compounds (VOC's) in the breath of participants with stage 1 lung cancer, their house-mates, and matched controls. The goal of the study is to identify VOC fingerprints that are only detectable in those with stage 1 lung cancer.
100 Clinical Results associated with Nanobeak, Inc.
0 Patents (Medical) associated with Nanobeak, Inc.
100 Deals associated with Nanobeak, Inc.
100 Translational Medicine associated with Nanobeak, Inc.